Crossmark

Time-Dependent Comparative Effectiveness of First-Line Treatment for Metastatic Clear Cell Renal Cell Carcinoma: A Restricted Mean Survival Time-Based Network Meta-analysis

Crossref DOI link: https://doi.org/10.1007/s11523-025-01194-w

Published Online: 2026-01-23

Published Print: 2026-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Fukushima, Hiroshi

Yajima, Shugo

Chen, Wei

Hirakawa, Akihiro

Tanabe, Kenji

Fujiwara, Motohiro

Arita, Yuki

Tanaka, Hajime

Masuda, Hitoshi

Fujii, Yasuhisa

Yoshida, Soichiro
License Information

Text and Data Mining valid from 2026-01-01

Version of Record valid from 2026-01-01
More Information

Article History

Received: 10 November 2025

Accepted: 30 December 2025

First Online: 23 January 2026

Declarations

:

: Hiroshi Fukushima, Shugo Yajima, Wei Chen, Akihiro Hirakawa, Kenji Tanabe, Motohiro Fujiwara, Yuki Arita, Hajime Tanaka, Hitoshi Masuda, Yasuhisa Fujii, and Soichiro Yoshida have no conflicts of interest that are directly relevant to the content of this article.

: Not applicable.

: Not applicable.

: Not applicable.

: The reconstructed individual patient data and analysis code used in this study are available from the corresponding author upon reasonable request.

: Not applicable.

: Conceptualization: HF, SY; methodology: HF, SY, WC, SY; formal analysis and investigation: HF, SY; writing (original draft preparation): HF; writing (review and editing): all authors; resources: HF; supervision: SY, YF.

Document is current

Any future updates will be listed below